The Challenges of Developing Biologics for Respiratory Delivery

Developing biologics for respiratory delivery presents a range of new challenges and  numerous factors need to combine to deliver a safe and efficacious drug product. The device, formulation, active substance, excipients and manufacturing processes all influence the performance, usability and functionality of the product and need careful consideration during development. During this webinar, DFE Pharma and Intertek will review key concepts and techniques in the formulation, design, and performance testing of the formulation of biologics for Dry Powder Inhalation. Topics will include stabilization of biologics and carrier-free particle engineering, as well as analytical approaches to characterise these products.